Mural Oncology PLC
Clinical-stage company developing cytokine immunotherapies for hard-to-treat solid tumors.
Overview
Corporate Details
- ISIN(s):
- IE000LK2BOB4
- LEI:
- Country:
- N/A
- Address:
- N/A
- Website:
- https://www.muraloncology.com/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
Mural Oncology PLC is a clinical-stage oncology company focused on developing novel immunotherapies to treat cancer. The company leverages its proprietary protein engineering platform and expertise in cytokine biology to design and advance a pipeline of cytokine-based therapies. Its mission is to unlock the value of immunotherapy for a broader range of patients, particularly those with cancers that have not responded to previous treatments. The company's lead candidate, nemvaleukin alfa, is a novel, engineered interleukin-2 (IL-2) variant immunotherapy currently in clinical trials for difficult-to-treat solid tumors, including advanced melanoma and platinum-resistant ovarian cancer.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Mural Oncology PLC and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Automate Your Workflow. Get a real-time feed of all Mural Oncology PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Mural Oncology PLC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
